Effective Cystine Level Lowering with Oral Administration of Delayed-Release Cysteamine Bitartrate in Young Infants with Cystinosis (PAS 2026) - Feb 25, 2026 - Abstract #2467.479; Pres time: Apr 25, 2026; 03:30 PM - 05:45 PM; Location: Poster Hall; "Case characteristics are summarized in Table 1. Age at diagnosis ranged from 3 to 27 months. DR cysteamine was taken orally with intact granules sprinkled onto foods such as applesauce, yogurt, and berry jelly, to prevent the medication's enteric coating from dissolving prior to its intended release in the small intestine."
Inflammation • Metabolic Disorders • Rare Diseases
|
|
Mallory Mandel; Avram Traum; Deborah R.. Stein
|